Status:
COMPLETED
"Platelet-Rich Plasma" Epidural Injection an Emerging Strategy in Lumbar Disc Herniation
Lead Sponsor:
Queen Savang Vadhana Memorial Hospital, Thailand
Conditions:
PRP
Eligibility:
All Genders
20-55 years
Phase:
NA
Brief Summary
To evaluate the efficacy of platelet-rich plasma (PRP; double-spin) in treatment of single-level lumbar herniated nucleus pulposus (HNP) in comparison to triamcinolone. RCT was conducted with 30 patie...
Detailed Description
The study was a randomized controlled trial, triple-blind, single-center/surgeon/assessor. The study was conducted between April 2019 to May 2021. We evaluated 30 patients (both genders) aged 20-55 ye...
Eligibility Criteria
Inclusion
- Age 20-55 years
- Having failed conservative treatment for at least 6 weeks
- Visual analogue scale (VAS) of greater than 30
- Confirmed a single-level HNP, corelated to clinical, by MRI.
Exclusion
- Previous spine surgery or epidural injection
- Progressive neurological deficit
- Cauda equina
- Coagulopathy-related conditions
- Associated cervical myelopathy
- Systemic bone and joint diseases
Key Trial Info
Start Date :
April 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 30 2021
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05234840
Start Date
April 1 2019
End Date
June 30 2021
Last Update
February 10 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chuenrutai
Chon Buri, Thailand, 20110